TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,156,045
|
3,564,331
|
2,930,547 |
Earnings before taxes |
476,648
|
1,087,801
|
984,512 |
Total assets |
5,465,294
|
4,868,654
|
4,212,230 |
Current assets |
1,807,936
|
2,054,643
|
2,833,193 |
Current liabilities |
3,288,822
|
2,745,173
|
2,524,971 |
Equity capital |
463,666
|
936,066
|
849,759 |
- share capital |
64,632
|
60,660
|
57,474 |
Employees (average) |
350
![]() |
350
![]() |
350 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
8.5%
|
19.2%
|
20.2% |
Turnover per employee |
9,017
|
10,184
|
8,373 |
Profit as a percentage of turnover |
15.1%
|
30.5%
|
33.6% |
Return on assets (ROA) | |||
Current ratio |
55.0%
|
74.8%
|
112.2% |
Return on equity (ROE) |
102.8%
|
116.2%
|
115.9% |
Change turnover |
-641,643
|
471,323
|
979,019 |
Change turnover % |
-17%
|
15%
|
50% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.